A deluge of weight‑loss drugs is set to transform the global fight against obesity as India prepares to unleash low‑cost generic versions of injections like Ozempic after a key patent expired Friday. While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Context Explanation

A weekly injection is no longer the only way to reap the obesity management and weight loss benefits of glucagon-like peptide-1 (GLP-1) medications. The U.S. Food and Drug Administration (FDA) has ... Healthline: Can You Maintain Weight Loss With Fewer Injections of Ozempic, Wegovy?

Insight Material

Share on Pinterest A small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections. Image Credit: Siluk/UCG/Universal Images Group via Getty Images A recent ... Reuters on MSN: India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation BRITS will be able to get their hands on a new triple-strength dose of the weight loss jab Wegovy within a month. The highest dose currently available in the UK is 2.4 mg. But a new once-weekly ...

Final Conclusion

MSN: India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top